Papers
5
Total Citations
70
H-Index
4
About
Dr. Takehiko Segawa is a leading Japanese urologic surgeon and researcher whose work centers on advancing minimally invasive techniques in urologic oncology, particularly robot-assisted surgery for prostate and kidney cancers. His most impactful contribution is the landmark 2019 multicenter study on “Trifecta” outcomes of robot-assisted partial nephrectomy, which has garnered 52 citations and established a benchmark for surgical success in kidney cancer treatment. Dr. Segawa has also made critical contributions to perioperative management, notably in his 2024 cohort study examining the effects of thienopyridine-class antiplatelet agents on bleeding outcomes following robot-assisted radical prostatectomy—a practical guide for surgeons managing high-risk patients. His case reports, including a novel use of near-infrared ray catheter with indocyanine green for delayed ureteral reconstruction and a rare documentation of port-site metastasis after prostatectomy, demonstrate his innovative problem-solving and commitment to improving surgical safety. Additionally, his 2024 work on neurovascular bundle preservation’s impact on biochemical recurrence in high-risk prostate cancer patients reflects his dedication to optimizing oncologic outcomes while preserving quality of life. With a career spanning over a decade of pioneering robotic surgery research, Dr. Segawa continues to shape best practices in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5